Polyglycolic Acid Market Report Scope & Overview:

The Polyglycolic Acid Market was valued at USD 6.28 Billion in 2025 and is expected to reach USD 15.87 Billion by 2035, growing at a CAGR of 9.72% from 2026–2035.

Polyglycolic acid is extremely special among industrial polymers since it not only possesses biodegradable properties, but also is strong enough to withstand harsh conditions, thus being used in manufacturing surgical sutures that can degrade over time and in making environmentally-friendly packaging films. Growing application in the field of medicine is currently the only major factor that drives the development of the market, as PGA can be used as an implant that degrades without causing any harm. The mechanical strength and biocompatibility of the material contribute to the growing demand due to the increasing amount of surgery cases.

The volume of PGA used in medical applications alone is projected to reach 38,334.1 tonnes by 2031, a figure that highlights the material's increasing significance within global healthcare specifically. The U.S. Food and Drug Administration has registered PGA-based absorbable sutures for general soft tissue approximation and ligation, a regulatory foundation that continues to support accelerated expansion of the polyglycolic acid market across medical applications.

Market Size and Forecast

• Market Size in 2026E: USD 6.89 Billion

• Market Size by 2035: USD 15.87 Billion

• CAGR: 9.72% from 2026 to 2035

• Fastest Growing Region: Asia Pacific

• Largest Region: North America

Polyglycolic Acid Market Trends

• Biodegradable PGA packaging films are gaining adoption as industries shift away from conventional plastics.

• Bio-based PGA production technologies are advancing to improve sustainability and reduce fossil fuel dependence.

• Advanced PGA surgical sutures with antibacterial and drug-eluting properties are expanding medical applications.

• Growing use of PGA in tissue engineering and regenerative medicine is driving demand for advanced biomaterials.

• Government support for biodegradable materials is accelerating industrial adoption of polyglycolic acid.

The U.S. Polyglycolic Acid Market Outlook

The U.S. Polyglycolic Acid Market was valued at approximately USD 1.96 Billion in 2025 and is expected to reach approximately USD 4.80 Billion by 2035, growing at a CAGR of approximately 9.39%.

The factors contributing to growth in the United States market include the presence of highly developed healthcare infrastructure, adoption of advanced medical technology, and sustainability as an important issue in major domestic sectors. The high number of surgical operations performed domestically in addition to the trend towards less-invasive surgery operations keeps up a good demand for PGA material among surgeons. In addition, the existence of a highly developed industry for medical devices means that there is extensive use of PGA material in medical sutures, implants, and tissue engineering within the country.

In June 2024, researchers at National Taiwan University Hospital advanced a clinical study using absorbable polyglycolic acid mesh combined with fibrin glue to prevent postoperative cerebrospinal fluid leakage in patients undergoing pituitary and skull base tumor surgery. While conducted outside the U.S., the study reflects the kind of expanding clinical application for PGA-based materials that continues to inform surgical practice and product development within the American medical device industry as well.

Polyglycolic Acid Market Segment Analysis

• By Form, the fibers segment dominated the polyglycolic acid market with approximately 48% share in 2025, while the films segment is expected to grow fastest during the forecast period.

• By End-use Industry, the medical segment dominated the polyglycolic acid market with approximately 32% share in 2025, while the packaging segment is expected to grow fastest during the forecast period.

By Form, fibers dominate the market

The largest market share of 48% was registered in the form of fibers in 2025 due to its wide application in the medical and textile sectors because of the special characteristics of PGA that give it a real competitive advantage. The high strength, biodegradability, and biocompatibility of PGA make it an excellent choice for sutures and tissue engineering because they can easily be absorbed in the body; on the other hand, increased consumer preference for green fibers in nonwoven textiles is expected to fuel the demand further.

Films held a significant secondary market share, increasingly becoming the preferred choice for biodegradable packaging and medical applications. PGA films offer superb resistance against gases and moisture, hence very useful for food packaging that requires extended shelf-life and minimal ecological footprint, while the increasing trend of environmentally friendly packaging and government ban of conventional plastic films are further fuelling the development of PGA films.

By End-use Industry, medical dominates, packaging holds significant share

The medical industry accounted for around 32% of total end use consumption in 2025, having the highest market share, attributed to the superior biocompatible and biodegradable nature of the material, making it ideal for medical purposes. PGA is largely employed in applications including surgical sutures, tissue engineering scaffolds, and implants, which degrade without causing any side effects and do not need surgery for removal, and increasing incidences of chronic disease, increasing number of surgical procedures being performed worldwide, and the increase in demand for minimally invasive surgeries have led to increased utilization of medical devices made from PGA.

Packaging was one of the major secondary markets for the polymer, with an increased demand resulting from growing environmental awareness and regulations. Manufacturers are in search of a replacement to plastics which not only causes pollution but also accumulates in landfills. With its outstanding biodegradability and good mechanical and barrier properties, PGA can be used for making packaging materials for those products where safety and shelf-life are important such as foods and pharmaceuticals. The increased consumer preference towards environmentally friendly packaging further encourages companies to use PGA in their packages instead of alternatives.

Regional Analysis

North America Polyglycolic Acid Market Insights

North America held the largest market share, at approximately 42.35% in 2025, supported by an established healthcare infrastructure and leading medical device manufacturers that widely use PGA for surgical sutures, implants, and tissue engineering applications. Increasing consumer awareness toward biodegradable materials, alongside stringent government regulation aimed at reducing plastic pollution, continues to expand usage of biodegradable materials including PGA across packaging and other related industries.

The region is characterized by a high level of research and development investment, alongside favorable policies stimulating the use of sustainable raw materials, both of which continue to boost innovation and market penetration. The United States accounts for the substantial majority of regional demand, supported by a deep medical device manufacturing base and consistent research investment in biodegradable polymer applications.

Europe Polyglycolic Acid Market Insights

Europe held a significant market share over the forecast period, owing to the region's high focus on sustainability, coupled with sophisticated healthcare infrastructure and stringent environmental regulation. Top pharmaceutical and medical device manufacturers located within the region readily use biodegradable polymers including PGA in their products, particularly for surgical sutures and tissue engineering applications.

A range of European companies have brought plastic-reducing, bio-based materials to market, and the broader goal of lowering plastic waste while advancing circular economy-based solutions has been prevalent across the continent, where a relatively large number of companies are adopting plastic-reducing packaging models. That combination of sustainability focus and healthcare infrastructure sophistication continues to position Europe as a technically advanced, if more measured, growth market relative to Asia Pacific and North America.

Asia Pacific Polyglycolic Acid Market Insights

Asia Pacific held a significant market share and is the fastest-growing region over the forecast period, owing to fast industrialization, expanding healthcare infrastructure, and rising awareness regarding the environmental benefits of biodegradable polymers. Growing end-user industries across China, Japan, and India are witnessing a boost in demand for biodegradable polymers, driven by the rapid growth of medical operations, particularly surgical procedures, across these countries, where PGA is extensively used for sutures and implants.

The region has also witnessed a significant rise in its packaging industry, which is increasingly turning to sustainable materials to conform to strict government regulation limiting plastic waste and pollution. The continuous increase in production capacity of PGA by Kureha Corporation in Japan due to high demand for the material as biodegradable packaging and medical use demonstrates its strategic significance in the global chain of PGA producers.

MEA & Latin America Polyglycolic Acid Market Insights

The Middle East and Africa are experiencing steady growth in polyglycolic acid demand, driven by expanding healthcare infrastructure and growing packaging industry investment across the UAE and Saudi Arabia. South Africa contributes meaningfully as well, supported by its more established industrial and healthcare sectors.

Latin America is seeing gradual growth led by Brazil, where medical device manufacturers and packaging companies are increasingly incorporating PGA into their product lines. Argentina follows as a smaller but growing contributor, and both regions remain more price-sensitive than North America, Europe, or Asia Pacific, keeping cost-competitive PGA grades the more common choice across broader industrial applications.

Market Dynamics

Growth Drivers: Rising packaging industry demand accelerates PGA adoption

The rising packaging industry represents one of the major factors driving polyglycolic acid market growth, as increased need for biodegradable, high-performance packaging solutions continues to expand. Given that PGA has excellent gas barrier properties, is biodegradable and strong, it is an excellent alternative for synthetic plastics which are derived from oil and have wide applications in food, pharmaceutical and industrial packaging. The increasing pressure to reduce plastic waste and be ecologically responsible is driving industries towards bio-based products such as PGA.

The capacity of PGA to contribute to sustaining the freshness of products by increasing their shelf-life through the food packaging application is another practical advantage contributing to the development of the market. The example of the investment plan of Jindal Poly Films, who will spend up to USD 84.34 million in the expansion of Nashik plant with the introduction of new BOPP, PET, and CPP film lines for enhancing its flexible packaging business, demonstrates such investments.

Restraints: Limited commercial availability constrains broader market adoption

The limited commercial availability of polyglycolic acid may represent a major drawback for market growth across end-use industries, particularly as demand for PGA increases across medical applications, packaging, and the oil and gas industry. Production of PGA remains bottlenecked among a small number of key manufacturers possessing proprietary technology and requiring very high capital investment, and this limited availability prohibits entry for smaller players and emerging market participants, slowing the overall pace of adoption.

The inability to produce locally in most parts of the world creates a dependency on importing materials from outside, causing increased costs as well as delays caused by uncertainties in global logistics systems. This combination of the concentration of manufacturing capabilities and importing from other areas remains a limiting factor in the translation of growth in demand into supply, especially among smaller end consumers without suppliers.

Opportunities: Bio-based production innovation creates substantial growth potential

Innovation in bio-based PGA production opens major opportunities for the market by overcoming important barriers including high production cost and environmental sustainability concerns. Conventional PGA synthesis is characterized by the use of expensive fossil fuel resources, which limits its ability to achieve industrial scale-up and environmentally-friendly process operation; however, recent advances in the areas of green chemistry and biotechnology are rapidly advancing cheap biological synthesis from renewable resources such as sugars and bacteria.

This way, not only are there no environmental footprints from the production process of PGA, but also this is a move that is in line with the sustainable development agenda since consumers now prefer products made from biodegradable and non-toxic substances. The fact that the US Department of Commerce granted $1.4 billion in January 2025 for the CHIPS National Advanced Packaging Manufacturing Program that seeks to promote US domination in advanced packaging and ensure that technologies transition from laboratory to domestic manufacturing reflects how serious the government is in packaging technology development.

Recent Developments:

• 2023: In 2023, PureTech Scientific LLC acquired the glycolic acid business from The Chemours Company, aligning with PureTech's strategy to broaden its product offering and enhance its position within the specialty chemicals industry.

• 2023: In 2023, Ethicon Inc. received clearance from NICE Medical Technologies Guidelines for its antibacterial-coated sutures, the first of their kind cleared for use by the UK's National Health Service.

• 2024: In June 2024, researchers at National Taiwan University Hospital advanced a clinical study using absorbable polyglycolic acid mesh combined with fibrin glue to prevent postoperative cerebrospinal fluid leakage following pituitary and skull base tumor surgery.

Polyglycolic Acid Market key players are:

• Kureha Corporation

• Evonik Industries AG

• BMG Incorporated

• Shenzhen Polymtek Biomaterial Co., Ltd.

• Foryou Medical

• Meta Biomed Co., Ltd.

• Huizhou Foryou Medical Devices Co., Ltd.

• Teleflex Incorporated

• Meril Life Sciences

• Johnson & Johnson (Ethicon Inc.)

• Medtronic plc

• B. Braun SE

• Ashland Inc.

• Toray Industries, Inc.

• Mitsubishi Chemical Corporation

• Gunze Limited

• Samyang Biopharmaceuticals Corporation

• Bezwada Biomedical LLC

• GC Aesthetics plc

• Synthecon, Inc.

Polyglycolic Acid Market Report Scope: